EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹8,122 Cr | ₹7,709 Cr | ₹6,573 Cr | ₹5,947 Cr | ₹6,659 Cr |
What is the latest Total Liabilities ratio of EMCURE PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹8,122 Cr |
Mar2024 | ₹7,709 Cr |
Mar2023 | ₹6,573 Cr |
Mar2022 | ₹5,947 Cr |
Mar2021 | ₹6,659 Cr |
How is Total Liabilities of EMCURE PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹8,122 Cr | 5.35 | |
Mar2024 | ₹7,709 Cr | 17.28 | |
Mar2023 | ₹6,573 Cr | 10.53 | |
Mar2022 | ₹5,947 Cr | -10.69 | |
Mar2021 | ₹6,659 Cr | - |
Compare Total Liabilities of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹26,507.3 Cr | 2.6% | 11.4% | 9.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹383,570.0 Cr | -1.9% | -4.1% | -6.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,808.0 Cr | -3.6% | -12.3% | 27.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,734.0 Cr | -2.1% | 7.2% | 9.3% | Stock Analytics | |
CIPLA | ₹120,468.0 Cr | -0.7% | -0% | -2.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,212.0 Cr | -1.6% | -5.4% | -12.1% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 2.6% |
11.4% |
9.4% |
SENSEX | -0.7% |
-3.7% |
2.4% |
You may also like the below Video Courses